Skip Navigation


Rheumatology Advance Access originally published online on April 14, 2008
Rheumatology 2008 47(6):840-848; doi:10.1093/rheumatology/ken109
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
47/6/840    most recent
ken109v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Do, J. E.
Right arrow Articles by Lee, E.-S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Do, J. E.
Right arrow Articles by Lee, E.-S.
Related Collections
Right arrow Vasculitis
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2008. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Effects of vitamin D on expression of Toll-like receptors of monocytes from patients with Behçet's disease

J. E. Do1, S. Y. Kwon1, S. Park2 and E.-S. Lee1

1Department of Dermatology and 2Department of Microbiology, Ajou University School of Medicine, Suwon, South Korea.

Correspondence to: E.-S. Lee, Department of Dermatology, Ajou University School of Medicine, 5 Wonchon-Dong, Yeongtong-Gu, Suwon 443-721, South Korea. E-mail: esl{at}ajou.ac.kr


  Abstract

Objectives. Recent studies have shown the immunomodulatory effect of vitamin D3 through down-regulation of Toll-like receptor (TLR) expression in human monocytes. To understand the implication of innate immunity with the role of vitamin D affecting TLR expression in Behçet's disease (BD), we focused on the association between the TLR expression and the serum vitamin D concentration in BD.

Methods. The expression of TLR2, TLR4 and CD16 on monocytes was detected by flow cytometric analysis and RT-PCR. Serum 25-hydroxyvitamin D [25(OH)D] levels were measured in the patients with BD, psoriasis and healthy controls, and then the expression of TLRs was correlated with the value of serum 25(OH)D levels. To assess the influence of vitamin D3 on expression and function of TLRs in vitro, human monocytes were treated with increasing concentrations of 1,25(OH)2D3.

Results. We found that the monocytes of active BD patients showed higher expressions of TLR2 and TLR4 than those of controls, and serum 25(OH)D levels tended to be lower in active BD. Furthermore, 25(OH)D levels were inversely correlated with the expressions of TLR2, TLR4 and clinical indicators. In vitro analysis showed that vitamin D3 was found to dose-dependently suppress the protein and mRNA expressions of TLR2 and TLR4. TNF-{alpha} synthesis was also decreased upon TLR ligand stimulation in vitamin D3-treated monocytes.

Conclusion. These results suggest that the inflammation triggered through TLR2 and TLR4 is important in the pathogenesis of BD. And it seems possible that vitamin D may be used as a therapeutic option by modulating TLR2 and TLR4 expression of monocytes in BD.

KEY WORDS: Behçet's disease, Monocyte, Toll-like receptors, Vitamin D

Submitted 25 October 2007; Accepted 14 February 2008


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.